AstraZeneca's vaccine hit its first roadblock with Indian regulators. Will lingering doubts derail its plans elsewhere?

British drugmaker AstraZeneca is already running behind early competitors in the hunt for a Covid-19 vaccine with interim data that have received less-than-stellar feedback. With those data in hand, India has said “no thanks” to an early approval for the shot, potentially setting the stage for even more setbacks.